Avalanche Biotechnologies Buried By Disappointing Data, Downgrades
June 16, 2015 at 14:35 PM EDT
Avalanche Biotechnologies Inc (NASDAQ: AAVL) dropped more than 50 percent Tuesday on a disappointing drug trial results and at least ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.